Back to search results
NCT05723926

Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation

Recruiting
NAAges 18+InterventionalPrevention
Javelin Medical
~2,000 participants
Updated 2026-06-09 on ClinicalTrials.gov
What's tested:Vine Filter

At a glance

Recruiting sites
5 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Large vessel occlusion strokes (efficacy)
Measured over 44 months
+2 more outcomes measured

Conditions

Atrial Fibrillation
Oral Anticoagulation
Stroke
Implant

Explore related trials

Atrial FibrillationIschemic Stroke

Where it's being run

7 sites across 5 states
Tennessee3
Illinois1
New York1
Canada1
Ontario1

Study leadership

  • Ashkan Shoamanesh, MD, FRCPC · PRINCIPAL_INVESTIGATOR · Population Health Research Institute, McMaster University
  • Alexander P Benz, MD MSc · PRINCIPAL_INVESTIGATOR · Population Health Research Institute

Who to contact

Sagit Broder, MSc
[email protected]
+972587112116
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Large vessel occlusion strokes (efficacy)44 months

    assessed by MRI/CTA

  • Serious device or procedure related complications (safety)44 months

    Defined as any carotid filter or procedure related complication (excluding ischemic stroke) that results in death) or major disability, or that requires endovascular stenting or surgical correction.

  • ISTH (International Society on Thrombosis and Haemostasis) major bleeding occurring during OAC + clopidogrel intake.44 months